ABCA1 and colorectal carcinoma: (iv) Metabolic intervention with ABCA1‐mediated cholesterol efflux, aiming to reverse the EMT phenotype of CRC cells caused by increased membrane fluidity, thereby inhibiting the motility and invasion of CRC cells.